Aspirin Protects Against Colorectal Cancer in Lynch Syndrome
Daily aspirin use for at least 2 years significantly reduced colorectal cancer risk among patients with Lynch syndrome, according to the 10-year follow-up of a randomized trial. Aspirin ’s protective effect did not become apparent until about 5 years after beginning treatment, the investigators reported in The Lancet.
Source: JAMA - Category: General Medicine Source Type: research
More News: Aspirin | Cancer | Cancer & Oncology | Colorectal Cancer | General Medicine | HNPCC | Lynch Syndrome